Caris Life Sciences, Inc.（CAI）價格預測CAICaris Life Sciences, Inc.

Alphio's CAI stock price prediction model matches the current Caris Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.49 (+0.01%). The 1-week path is $35.56 (+0.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Caris Life Sciences Inc is a good buy right now due to its current price of $32, which is supported by a strong gross margin of 68.10% in Q2 2026 and a forward P/E ratio of 43.29. The company has shown impressive revenue growth, with a 45.4% year-over-year increase in Q2 2026 revenue to $263.7 million, indicating strong market demand. However, the main risk is the high P/E ratio of 85.68, which suggests that the stock may be overvalued if growth expectations are not met.

Caris Life Sciences, Inc. (CAI) last closed at $35.4900017, gaining +5.41%. These facts feed the 1-day and 1-week CAI price prediction above.